Main Hight Light Publications
​
T1 mapping using MPRAGE acquisitions: application to the measurement of the concentration of theranostics agents in tumors
A. Lavielle, F. Boux, J. Deborne, N. Pinaud, S. Dufort, C. Verry, S. Grand, I. Tropres, C. Vecco-Garda. G. Le Duc, S. Mornet and Y. Crémillieux
Journal of Magnetic Resonance Imaging, 2022, DOI: 10.1002/jmri.28509
NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution
Clinical and Translational Radiation Oncology, 2024 (Vol. 48). https://doi.org/10.1016/j.ctro.2024.100833
​
Quantitative brain T1-mapping derived from T1-weighted MRI acquisitions : a proof-of-concept study
Audrey Lavielle; Noël Pinaud; Bei Zhang; Yannick Crémillieux
European Radiology Experimental, 2024, (8), 109 - DOI: 10.1186/s41747-024-00517-2
​
​
Audrey is a CIFRE PhD student supported by the company NH TherAguix. She graduated from Polytech Lyon biomedical engineering school in 2021 and she did her end-of-study internship in the Molecular MRI team. Then, she continued working with the team on a one-year engineering contract, working on MRI contrast agents based on iron oxide nanoparticles. She is currently a PhD student in the lab and is working on quantitative MRI of the biodistribution of gadolinium-based theranostic nanoparticles to assess their radiosensitizing effect.
​
​
​
Audrey is autor of 3 scientifics publications, 9 scientifics communications.
